GENE ONLINE|News &
Opinion
Blog

Reed Slater

WRITTEN BY Reed Slater

Sarepta Submits BLA for First-Ever Duchenne Muscular Dystrophy Gene Therapy
2022-10-03
Amylyx’s ALS Drug Nabs FDA Nod After Rare Regulatory Reversal
2022-09-29
Sanofi and Regeneron’s Dupixent Snags its Tenth Approval From the FDA
2022-09-29
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
ODAC Votes Against Oncopeptides’ and Spectrum’s New Oncology Drugs
2022-09-26
Spero Accepts GSK’s $66 Million to Save its Rejected Antibiotic
2022-09-23
Fennec’s PEDMARK Finally Gains FDA Approval to Treat Chemo-Induced Hearing Loss
2022-09-22
AVROBIO’s First-of-its-Kind Gene Therapy Receives Rare Pediatric Disease Designation
2022-09-21
Theravance Allots $250 Million to Repurchase Shares, Removing GSK as a Shareholder
2022-09-20
Bluebird’s Rare Childhood Neurodegenerative Gene Therapy Gains Accelerated Approval
2022-09-19
Pfizer’s Pentavalent Vaccine Shines in Phase 3 Trials Before BLA Submission
2022-09-16
MD Anderson and Radiopharm Theranostics Team Up to Develop Oncology Therapies
2022-09-14
WHO Urges Action After Model Suggests Over 17 Million Europeans Experienced Long COVID
2022-09-14
Competing With BMS’s New Psoriasis Drug, Nimbus Gathers $125 Million to Advance Development
2022-09-13
1 … 5 6 7 8 9 … 15
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top